212 related articles for article (PubMed ID: 34450310)
1. Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.
Gu X; Han YY; Yang CY; Ji HM; Lan YJ; Bi YQ; Zheng C; Qu J; Cheng MH; Gao J
Pharmacol Res; 2021 Nov; 173():105844. PubMed ID: 34450310
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis.
Penke LR; Speth JM; Dommeti VL; White ES; Bergin IL; Peters-Golden M
J Clin Invest; 2018 Jun; 128(6):2389-2405. PubMed ID: 29733296
[TBL] [Abstract][Full Text] [Related]
3. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
[TBL] [Abstract][Full Text] [Related]
5. AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis.
Bisserier M; Milara J; Abdeldjebbar Y; Gubara S; Jones C; Bueno-Beti C; Chepurko E; Kohlbrenner E; Katz MG; Tarzami S; Cortijo J; Leopold J; Hajjar RJ; Sassi Y; Hadri L
Mol Ther; 2020 Feb; 28(2):394-410. PubMed ID: 31879190
[TBL] [Abstract][Full Text] [Related]
6. Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGFβRI/FoxM1/Smad/β-catenin pathway.
Xie H; Gao YM; Zhang YC; Jia MW; Peng F; Meng QH; Wang YC
J Cell Mol Med; 2020 Dec; 24(23):13913-13926. PubMed ID: 33179861
[TBL] [Abstract][Full Text] [Related]
7. Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression.
Lan YJ; Cheng MH; Ji HM; Bi YQ; Han YY; Yang CY; Gu X; Gao J; Dong HL
Acta Pharmacol Sin; 2023 May; 44(5):1029-1037. PubMed ID: 36333557
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation.
Shi W; Hao J; Wu Y; Liu C; Shimizu K; Li R; Zhang C
Eur J Pharmacol; 2022 Apr; 921():174825. PubMed ID: 35283110
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of Ramelteon on bleomycin-induced pulmonary fibrosis in mice.
Zhang L; Cheng T; Chen W; Zhong C; Li M; Xie Y; Deng Q; Wang H; Yang Z; Ju J; Liang H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4153-4163. PubMed ID: 38032492
[TBL] [Abstract][Full Text] [Related]
11. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways.
Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P
Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334
[TBL] [Abstract][Full Text] [Related]
12. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
13. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
14. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway.
Han X; Yuan T; Zhang J; Shi Y; Li D; Dong Y; Fan S
J Cell Mol Med; 2022 Jun; 26(11):3269-3280. PubMed ID: 35510614
[TBL] [Abstract][Full Text] [Related]
15. Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling.
Cheng D; Xu Q; Wang Y; Li G; Sun W; Ma D; Zhou S; Liu Y; Han L; Ni C
J Transl Med; 2021 Aug; 19(1):349. PubMed ID: 34399790
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMPK α2 inhibits airway smooth muscle cells proliferation.
Liu L; Pan Y; Song Y; Su X; Ke R; Yang L; Gao L; Li M
Eur J Pharmacol; 2016 Nov; 791():235-243. PubMed ID: 27600020
[TBL] [Abstract][Full Text] [Related]
17. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
19. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
20. Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts.
Lu J; Shi J; Li M; Gui B; Fu R; Yao G; Duan Z; Lv Z; Yang Y; Chen Z; Jia L; Tian L
Life Sci; 2015 Apr; 127():59-65. PubMed ID: 25744403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
